Handing control to the patient - structured education in diabetes

IF 0.4 Q4 ENDOCRINOLOGY & METABOLISM British Journal of Diabetes Pub Date : 2022-12-22 DOI:10.15277/bjd.2022.363
S. Heller
{"title":"Handing control to the patient - structured education in diabetes","authors":"S. Heller","doi":"10.15277/bjd.2022.363","DOIUrl":null,"url":null,"abstract":"This year we celebrate the centenary of the discovery of insulin, when researchers at the University of Toronto successfully treated the first individual with T1DM. It was undoubtedly a major breakthrough. Insulin transformed children and adults destined to die within 2-3 years into healthy individuals within a few weeks and many went on to live full and productive lives. Yet the optimism that the ready availability of insulin would result in a cure for a previously fatal disease was gradually replaced by a realisation that insulin was not a panacea. Over the years that followed, many of those on treatment developed serious microvascular complications resulting in blindness, amputation and renal failure. It gradually became clear that keeping glucose levels close to normal was key. But since blood glucose had to be measured in hospital labs and those with diabetes were only able to measure glucose in their urine the challenges of keeping levels at target were immense. Episodes of severe hypoglycaemia were common, and many authorities considered it too dangerous to attempt to keep glucose at near-normal levels. With the advent of glucose monitoring in the late 1970s, pioneers such as Berger and Mühlhauser realised that this revolutionary technology could be used by patients at home to enable them to manage their diabetes themselves. Positive trial results were ignored by many healthcare professionals and it took another 30 years for the UK diabetes establishment to adopt this approach. In this chapter I describe how structured education in diabetes was developed, the evidence for its effectiveness and the remaining challenges which still need to be overcome. Following the discovery of insulin, most healthcare professionals were slow to realise that it is the person with diabetes (or their family) who holds the key to implementing effective self-management. Yet there were some professionals around the world who grasped this. Perhaps the first was Elliot Joslin, who was working in Boston when insulin was discovered. He realised rapidly that for treatment to work properly the patients had to be trained to be their own doctors and had to learn to adjust insulin themselves. He wrote a manual for patients in the early 1920s and, in a paper he wrote in 1946, he reflected that any insulin therapy was \"a waste of time and money unless the patient was thoroughly instructed to manage his own case”.1 Karl Stolte, a paediatrician working in Rostock in Germany, argued in 1929 that children should be allowed to eat freely with insulin adjusted according to the amount of glucose in their urine.2 It appears this was too much for the medical mainstream in Germany at that time and his insights went unheeded. Some British physicians did grasp the importance of self-management. RD Lawrence, whose own life was saved by the discovery of insulin, became head of the diabetes department at King’s College Hospital and by 1929 had written two books, “The Diabetic Life” and “The Diabetic ABC” which provided instruction on managing diabetes for both professionals and patients.3 However, the general view in the UK was that doctors should remain in charge of treatment. Robert Tattersall, who together with Peter Sönksen and Clara Lowy were the first clinicians to introduce blood glucose monitoring into clinical practice in 1977, has written that an abstract, describing the Nottingham experience in using the technology in pregnancy, was rejected by the then BDA Medical and Scientific meeting. Furthermore, during the subsequent meeting, the proposition that patients could monitor their own blood glucose was met ‘with incredulity’ and a view that even if it was possible, ‘it would be dangerous’.3 Yet at the same time, others in Europe realised the potential of self‐monitoring of blood glucose (SMBG) to transform diabetes care by using the technology as part of a structured training package. Jean Philippe Assal had, with others, developed the concept of Therapeutic Education,4 an approach incorporating principles of modern adult education to promote self-management skills encouraging patient autonomy. Muḧlhauser and Berger, working in the WHO centre in Dus̈seldorf, incorporated SMBG into a structured education course diabetes teaching and treatment programme (DTTP).5 They attempted to reproduce the physiology of insulin secretion therapeutically by separating insulin delivery into a longer-acting basal insulin (with NPH insulin injected twice daily) to control blood glucose in between meals and they covered meals with soluble insulin given before eating. In the UK, carbohydrate exchanges had been used to impose a rigid eating pattern in response to fixed doses of insulin prescribed by the physician, which meant expecting adults and children to eat the same amount of carbohydrate (CHO) at the same time each day. In marked contrast, the DTTP promoted ‘dietary freedom’, with no forbidden foods and those with diabetes calculating their own insulin dose based on anticipated CHO intake and current Address for correspondence: Simon Heller Room FU24, School of Medicine and Biosciences, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK E-mail: s.heller@sheffield.ac.uk","PeriodicalId":42951,"journal":{"name":"British Journal of Diabetes","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15277/bjd.2022.363","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

This year we celebrate the centenary of the discovery of insulin, when researchers at the University of Toronto successfully treated the first individual with T1DM. It was undoubtedly a major breakthrough. Insulin transformed children and adults destined to die within 2-3 years into healthy individuals within a few weeks and many went on to live full and productive lives. Yet the optimism that the ready availability of insulin would result in a cure for a previously fatal disease was gradually replaced by a realisation that insulin was not a panacea. Over the years that followed, many of those on treatment developed serious microvascular complications resulting in blindness, amputation and renal failure. It gradually became clear that keeping glucose levels close to normal was key. But since blood glucose had to be measured in hospital labs and those with diabetes were only able to measure glucose in their urine the challenges of keeping levels at target were immense. Episodes of severe hypoglycaemia were common, and many authorities considered it too dangerous to attempt to keep glucose at near-normal levels. With the advent of glucose monitoring in the late 1970s, pioneers such as Berger and Mühlhauser realised that this revolutionary technology could be used by patients at home to enable them to manage their diabetes themselves. Positive trial results were ignored by many healthcare professionals and it took another 30 years for the UK diabetes establishment to adopt this approach. In this chapter I describe how structured education in diabetes was developed, the evidence for its effectiveness and the remaining challenges which still need to be overcome. Following the discovery of insulin, most healthcare professionals were slow to realise that it is the person with diabetes (or their family) who holds the key to implementing effective self-management. Yet there were some professionals around the world who grasped this. Perhaps the first was Elliot Joslin, who was working in Boston when insulin was discovered. He realised rapidly that for treatment to work properly the patients had to be trained to be their own doctors and had to learn to adjust insulin themselves. He wrote a manual for patients in the early 1920s and, in a paper he wrote in 1946, he reflected that any insulin therapy was "a waste of time and money unless the patient was thoroughly instructed to manage his own case”.1 Karl Stolte, a paediatrician working in Rostock in Germany, argued in 1929 that children should be allowed to eat freely with insulin adjusted according to the amount of glucose in their urine.2 It appears this was too much for the medical mainstream in Germany at that time and his insights went unheeded. Some British physicians did grasp the importance of self-management. RD Lawrence, whose own life was saved by the discovery of insulin, became head of the diabetes department at King’s College Hospital and by 1929 had written two books, “The Diabetic Life” and “The Diabetic ABC” which provided instruction on managing diabetes for both professionals and patients.3 However, the general view in the UK was that doctors should remain in charge of treatment. Robert Tattersall, who together with Peter Sönksen and Clara Lowy were the first clinicians to introduce blood glucose monitoring into clinical practice in 1977, has written that an abstract, describing the Nottingham experience in using the technology in pregnancy, was rejected by the then BDA Medical and Scientific meeting. Furthermore, during the subsequent meeting, the proposition that patients could monitor their own blood glucose was met ‘with incredulity’ and a view that even if it was possible, ‘it would be dangerous’.3 Yet at the same time, others in Europe realised the potential of self‐monitoring of blood glucose (SMBG) to transform diabetes care by using the technology as part of a structured training package. Jean Philippe Assal had, with others, developed the concept of Therapeutic Education,4 an approach incorporating principles of modern adult education to promote self-management skills encouraging patient autonomy. Muḧlhauser and Berger, working in the WHO centre in Dus̈seldorf, incorporated SMBG into a structured education course diabetes teaching and treatment programme (DTTP).5 They attempted to reproduce the physiology of insulin secretion therapeutically by separating insulin delivery into a longer-acting basal insulin (with NPH insulin injected twice daily) to control blood glucose in between meals and they covered meals with soluble insulin given before eating. In the UK, carbohydrate exchanges had been used to impose a rigid eating pattern in response to fixed doses of insulin prescribed by the physician, which meant expecting adults and children to eat the same amount of carbohydrate (CHO) at the same time each day. In marked contrast, the DTTP promoted ‘dietary freedom’, with no forbidden foods and those with diabetes calculating their own insulin dose based on anticipated CHO intake and current Address for correspondence: Simon Heller Room FU24, School of Medicine and Biosciences, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK E-mail: s.heller@sheffield.ac.uk
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
将控制权交给糖尿病患者结构教育
今年,我们庆祝胰岛素发现一百周年,多伦多大学的研究人员成功治疗了第一例T1DM患者。这无疑是一个重大突破。胰岛素在几周内将注定在2-3年内死亡的儿童和成年人转变为健康人,许多人继续过着充实而富有成效的生活。然而,胰岛素的现成可用性将治愈一种以前致命的疾病的乐观情绪逐渐被胰岛素不是万能药的认识所取代。在随后的几年里,许多接受治疗的人出现了严重的微血管并发症,导致失明、截肢和肾衰竭。逐渐清楚的是,保持血糖水平接近正常是关键。但由于血糖必须在医院实验室进行测量,而糖尿病患者只能测量尿液中的血糖,因此将血糖水平保持在目标水平的挑战是巨大的。严重低血糖发作很常见,许多当局认为试图将血糖保持在接近正常水平太危险了。随着20世纪70年代末血糖监测的出现,Berger和Mühlhauser等先驱意识到,这项革命性的技术可以被家中的患者使用,使他们能够自己管理糖尿病。阳性试验结果被许多医疗保健专业人员忽视,英国糖尿病机构又花了30年时间才采用这种方法。在本章中,我描述了糖尿病结构化教育是如何发展的,其有效性的证据以及仍需克服的剩余挑战。在发现胰岛素后,大多数医疗保健专业人员都迟迟没有意识到,糖尿病患者(或其家人)才是实施有效自我管理的关键。然而,世界各地也有一些专业人士掌握了这一点。也许第一个是Elliot Joslin,当胰岛素被发现时,他正在波士顿工作。他很快意识到,为了使治疗正常进行,患者必须接受培训,成为自己的医生,并学会自己调整胰岛素。他在20世纪20年代初为病人写了一本手册,在1946年写的一篇论文中,他认为任何胰岛素治疗都是“除非患者得到彻底的指导来处理自己的病例,否则这是浪费时间和金钱”。1德国罗斯托克的儿科医生卡尔·斯托尔特在1929年提出,应该允许儿童自由进食,并根据尿液中的葡萄糖量调整胰岛素。2这对当时德国的主流医学来说似乎太过分了,他的见解没有得到证实注意。一些英国医生确实意识到了自我管理的重要性。RD Lawrence的生命因胰岛素的发现而得以挽救,他成为国王学院医院糖尿病科主任,到1929年,他写了两本书,《糖尿病生活》和《糖尿病ABC》,为专业人员和患者提供了管理糖尿病的指导。3然而,英国的普遍观点是,医生应该继续负责治疗。1977年,Robert Tattersall与Peter Sönksen和Clara Lowy一起成为第一批将血糖监测引入临床实践的临床医生。此外,在随后的会议上,患者可以监测自己血糖的提议遭到了“怀疑”,并认为即使可能,“也会很危险”。3然而,与此同时,欧洲的其他人意识到了血糖自我监测(SMBG)的潜力,通过将该技术作为结构化培训包的一部分来改变糖尿病护理。Jean-Philippe Assal和其他人一起提出了治疗教育的概念,4这是一种结合现代成人教育原则的方法,旨在促进自我管理技能,鼓励患者自主。Muḧ在杜塞尔多夫世界卫生组织中心工作的lhauser和Berger,将SMBG纳入结构化教育课程糖尿病教学和治疗计划(DTTP)。5他们试图通过将胰岛素输送分离为长效基础胰岛素(每天注射两次NPH胰岛素)来控制餐间血糖,从而在治疗上再现胰岛素分泌的生理学,并在餐前给予可溶性胰岛素。在英国,碳水化合物交换被用来强加一种严格的饮食模式,以应对医生开出的固定剂量的胰岛素,这意味着成人和儿童每天在同一时间摄入相同量的碳水化合物(CHO)。 与此形成鲜明对比的是,DTTP提倡“饮食自由”,没有违禁食品,糖尿病患者根据预期的CHO摄入量和当前通信地址计算自己的胰岛素剂量:Simon Heller,英国谢菲尔德大学医学与生物科学学院FU24室,谢菲尔德比奇山路S10 2RX电子邮件:s.heller@sheffield.ac.uk
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
British Journal of Diabetes
British Journal of Diabetes ENDOCRINOLOGY & METABOLISM-
自引率
16.70%
发文量
15
期刊最新文献
ABCD News Congenital hyperinsulinism: a family case report factors predicting glucose and weight response to injectable semaglutide (Ozempic): real-world data from the Association of British Clinical Diabetologists’ audit programme Fibrates: past history or renaissance? PCSK9 inhibitor therapy: delayed-onset cutaneous reactions
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1